Research grants to be awarded at Linde Healthcare REALfund event, 8 September 2014 concurrent with the European Respiratory Society Congress in Munich.
Pullach, Germany; 8 September 2014 – Linde Healthcare, a global business unit of The Linde Group, today announced the new beneficiaries of its REALfund initiative, a programme supporting ideas and projects with the potential to improve patient outcomes and health economics across the wide field of respiratory medicine.
Selected from more than 30 applications, three grantees of the REALfund will receive funds to support their innovative research:
Professor Philipp Latzin MD, PhD, University Children Hospital, Basel, Switzerland is researching how to help transfer double tracer gas single-breath washout, an innovative robust, inexpensive, fast and sensitive diagnostic method for small airway disease, into clinics.
Professor Stefan Mihaicuta, MD, PhD FCCP, V. Babes University of Medicine and Pharmacy, Romania is working on implementation of a new methodology for early diagnosis and continuous patient management of sleep apnoea, based on an e-health system facilitated by complex networks science.
Torbjörn L Möller, CareTelCom AB, Veberöd, Sweden is developing and verifying a predictive algorithmic system for early detection of potentially upcoming exacerbations in patients suffering from chronic obstructive pulmonary disease (COPD).
Dr Christian Wojczewski, Head of Linde Healthcare states: “Linde Healthcare continues to be committed to co-operating with researchers from around the world to support research and innovative developments in the area of respiratory care. The newly awarded REALfund grants span a diverse range of research areas – from the transfer of gas-based diagnostic methods into routine clinics, to new methodology for early diagnosis and patient management of sleep apnea. The grants also include a new system for prediction of acute exacerbations in patients suffering from COPD. The work of these researchers, when realised, will help healthcare professionals, support healthcare systems and further improve the quality of care and life for patients”.
Grantees of the REALfund are selected with the help of medical and scientific experts and will be supported in their continued research. Dr Konstantin Fiedler, Head of Innovation and Development at Linde Healthcare states: “The aim of Linde Healthcare’s REALfund initiative is to seek and reward ideas that have real potential to be developed into better respiratory care solutions for patients. We commend all applicants to the fund for their commitment to innovation and idea development in this area of healthcare. The grantees saw the potential in their projects and we at Linde Healthcare are delighted to recognise and reward the ideas that will truly benefit patients.”
The REALfund event and awards ceremony will take place on 8 September 2014 concurrent with the European Respiratory Society (ERS) Congress in Munich, Germany. Further information about the REALfund is available at: www.linde-healthcare-realfund.com
REALfund grantees project titles:
Professor Philipp Latzin MD, PhD - Project title: ‘Clinical application of double tracer gas single-breath washout in children with different lung diseases.’
Professor Stefan Mihaicuta, MD, PhD FCCP - Project title: ‘Morpheus: A Screening and Monitoring System for Sleep Apnea Syndrome.
Torbjörn L Möller - Project title: ‘Mathematical algorithms for early prediction of increasing probability for soon up-coming exacerbation.’
Press ContactAnne Mette Schrade, Linde Healthcare
Phone: + 49 – 89 – 7446-2247
Võta meiega ühendust
Kui sul on küsimusi või vajad lisainformatsiooni, võta meiega ühendust.Saada e-kiri